SearchDictionaryMobileLogin

M Cutolo Selected Research

Rheumatoid Arthritis

01/2008Impact of long-term anti-TNF-alpha treatment on insulin resistance in patients with rheumatoid arthritis.
01/2007Quantitative determination of steroid hormone receptor positive cells in the synovium of patients with rheumatoid arthritis and osteoarthritis: is there a link to inflammation?
11/2006Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with adalimumab.
11/2006Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis.
11/2006Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe.
07/2006Recommendations for the use of biologic (TNF-alpha blocking) agents in the treatment of rheumatoid arthritis in Italy.
07/2006No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis.
06/2006Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients.
01/2006Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.
09/2005Anti-tumour necrosis factor antibody treatment does not change serum levels of cortisol binding globulin in patients with rheumatoid arthritis but it increases androstenedione relative to cortisol.
08/2005The melatonin-cytokine connection in rheumatoid arthritis.
05/2005Is there a rationale to using leflunomide in early rheumatoid arthritis?
04/2005[Effects of estrogen peripheral metabolism in rheumatoid arthritis.]
02/2005Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison.
01/2005The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis.
11/2003New roles for estrogens in rheumatoid arthritis.
04/2003Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis.
11/2002Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines.
11/2002Melatonin in rheumatoid arthritis: a disease-promoting and modulating hormone?
09/2002Effects of DMARDs on IL-1Ra levels in rheumatoid arthritis: is there any evidence?
06/2002Melatonin serum levels in rheumatoid arthritis.
01/2002Sex hormone adjuvanting therapy in rheumatoid arthritis.
11/2001Etanercept improves rheumatoid arthritis partially responsive to methotrexate.
09/2001Homocysteine and antiphospholipid antibodies in rheumatoid arthritis patients: relationships with thrombotic events.
08/2001Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis.
11/2000Neurotransmitter modulation of interleukin 6 (IL-6) and IL-8 secretion of synovial fibroblasts in patients with rheumatoid arthritis compared to osteoarthritis.
11/2000Antiproliferative and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (THP-1) but not on synovial macrophages from patients with rheumatoid arthritis.
11/2000Sex hormone adjuvant therapy in rheumatoid arthritis.
09/2000Recent aspects of gonadal hormone and neurotransmitter interactions with synovial and immune cells: implications in rheumatoid arthritis.
05/2000CYP17 polymorphisms and androgen levels in postmenopausal patients with rheumatoid arthritis.

Articles by Research Topic

Disease

30Rheumatoid Arthritis
01/2008 - 05/2000
5Systemic Scleroderma (Systemic Sclerosis)
04/2007 - 10/2001
3Psoriatic Arthritis
01/2008 - 10/2001
3Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
11/2006 - 06/2000
3Necrosis
07/2006 - 06/2000
2Osteoarthritis
01/2007 - 11/2000
2Rheumatic Diseases (Rheumatism)
10/2001 - 11/2000
1Insulin Resistance
01/2008
1Inflammation
01/2007
1Visceral Leishmaniasis (Kala Azar)
11/2006
1Infection
11/2006
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2006
1Leukemia
08/2001

Drug/Important Bio-Agent (IBA)

7HormonesIBA
01/2008 - 09/2000
5Methotrexate (Mexate)FDA LinkGeneric
06/2006 - 11/2000
4Hydrocortisone (Cortisol)FDA LinkGeneric
01/2008 - 06/2002
4MelatoninIBA
08/2005 - 06/2002
3CytokinesIBA
11/2006 - 06/2000
3leflunomide (Arava)FDA LinkGeneric
06/2006 - 04/2003
3Estrogens (Estrogen)FDA Link
04/2005 - 11/2000
3Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2001 - 10/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2008 - 07/2006
2TNFR-Fc fusion protein (etanercept)FDA Link
01/2008 - 11/2001
2adalimumab (Humira)FDA Link
11/2006 - 07/2006
2Androstenedione (4 Androstene 3,17 dione)IBA
09/2005 - 06/2002
2AutoantibodiesIBA
06/2004 - 01/2004
2AndrogensIBA
10/2001 - 11/2000
2Neurotransmitter Agents (Neurotransmitter)IBA
11/2000 - 09/2000
2Interleukin-6 (Interleukin 6)IBA
11/2000 - 06/2000
1Endothelin-1 (Endothelin 1)IBA
04/2007
1Vitamin DFDA LinkGeneric
11/2006
1LeptinIBA
07/2006
1AdiponectinIBA
07/2006
1Carbon MonoxideIBA
06/2006
1Neuropeptide YIBA
01/2006
1cortisol binding globulinIBA
09/2005
1GlucocorticoidsIBA
01/2005
1AdenosineFDA LinkGeneric
11/2002
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
09/2002
1Dehydroepiandrosterone SulfateIBA
06/2002
1Sulfasalazine (Azulfidine)FDA LinkGeneric
10/2001
1Antiphospholipid AntibodiesIBA
09/2001
1HomocysteineIBA
09/2001
1phorbolIBA
08/2001
1Estrogen ReceptorsIBA
08/2001
1Interleukin-8 (Interleukin 8)IBA
11/2000
1Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
05/2000